Exor N.V. (0RKY.IL)
| Previous close | 101.25 |
| Open | 102.50 |
| Bid | 99.25 x 0 |
| Ask | 103.50 x 0 |
| Day's range | 101.00 - 102.70 |
| 52-week range | 73.24 - 105.20 |
| Volume | |
| Avg. volume | 65,065 |
| Market cap | 35.627B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 6.36 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.44 (0.53%) |
| Ex-dividend date | 02 Jun 2023 |
| 1y target est | N/A |
- Reuters
Agnellis' Exor targets growth in healthcare sector
Exor, the investment arm of the Agnelli family, has a growing interest in the healthcare industry, where it has already invested almost 4 billion euros ($4.3 billion), CEO John Elkann said on Thursday. "The increased cost of healthcare services combined with a shortage of medical staff is driving demand for innovative new approaches to tackle global health problems," he said in his annual letter to Exor shareholders. Exor views healthcare as a "long-term, structural growth sector," added Elkann, the scion of the Agnelli family and chair of automakers Stellantis and Ferrari.
- Reuters
UPDATE 1-Agnellis' Exor targets growth in healthcare sector
Exor, the investment arm of the Agnelli family, has a growing interest in the healthcare industry, where it has already invested almost 4 billion euros ($4.3 billion), CEO John Elkann said on Thursday. "The increased cost of healthcare services combined with a shortage of medical staff is driving demand for innovative new approaches to tackle global health problems," he said in his annual letter to Exor shareholders. Exor views healthcare as a "long-term, structural growth sector," added Elkann, the scion of the Agnelli family and chair of automakers Stellantis and Ferrari.
- Reuters
Exor has growing interest in healthcare industry
Exor, the investment arm of the Agnelli family, has a growing interest in the healthcare industry, where it has already invested almost 4 billion euros ($4.3 billion), CEO John Elkann said on Thursday. "The increased cost of healthcare services combined with a shortage of medical staff is driving demand for innovative new approaches to tackle global health problems," he said in his annual letter to Exor shareholders. Exor views healthcare as a "long-term, structural growth sector," said Elkann, the scion of the Agnelli family and chair of automakers Stellantis and Ferrari.
